Drug discontinued-text Specifically, the following presentations will no longer be available: 125mg/5mL; 100mL bottles (anticipated final date of availability: April 1, 2018), 250mg/5mL; 50mL bottles ...
Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to manufacture and market cefuroxime axetil for oral suspension USP, 125 mg / 5mL and 250 mg / 5mL, which will ...
GlaxoSmithKline Plc said on Wednesday it had filed for a preliminary injunction seeking to prevent Canada's Apotex from selling a generic version of GSK's Ceftin antibiotic in the US market. Apotex ...
MUMBAI: Ranbaxy Laboratories said on Friday its quarterly profit fell 4.4 per cent as competition ate into sales of its generic Ceftin antibiotic for which it had enjoyed a monopoly a year ago. MUMBAI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results